Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Astellas Pharma Inc (OTC Pink - Current Information:ALPMY)

15.64
Delayed Data
As of Aug 30
 -0.05 / -0.32%
Today’s Change
12.50
Today|||52-Week Range
19.40
+9.29%
Year-to-Date
Dear Pfizer, Stop Overpaying for Acquisitions!
Aug 24 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Bought Medivation (MDVN), but is it a Good Deal?
Aug 22 / Zacks.com - Paid Partner Content
What Pfizer Gets in Its $14 Billion Medivation Deal
Aug 23 / MotleyFool.com - Paid Partner Content
Medivation's Shares Soar on Confirmation of a Pfizer Buyout
Aug 22 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close15.69
Today’s open15.51
Day’s range15.51 - 15.70
Volume83,434
Average volume (3 months)193,103
Market cap$33.1B
Dividend yield1.96%
Data as of 3:59pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+34.03%
Earnings growth (this year)+21.87%
Earnings growth (next 5 years)+5.47%
Revenue growth (last year)+1.08%
P/E ratio--
Price/Sales2.52
Price/Book2.98

Competitors

No competitors data available.

Financials

Next reporting dateOctober 28, 2016
EPS forecast (this quarter)$0.21
Annual revenue (last year)$11.4B
Annual profit (last year)$1.6B
Net profit margin14.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Representative Director
Yoshihiko Hatanaka
Senior Executive Officer &
Head-Finance
Yasumasa Masuda
Corporate headquarters
Tokyo, Tokyo

Forecasts

Search for Jobs